Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma

详细信息    查看全文

• 作者：Soon Sun Kim ; Ji Sun Nam ; Hyo Jung Cho ; Je Hwan Won ; Jin Woo Kim ; Jae-Hoon Ji ; Min Jae Yang ; Joo Han Park ; Choong-Kyun Noh ; Sung Jae Shin ; Kee Myung Lee ; Sung Won Cho and Jae Youn Cheong
• 刊名：Journal of Gastroenterology and Hepatology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：32
• 期：1
• 页码：199-207
• 全文大小：270K
• ISSN：1440-1746

文摘

Circulating microRNA (miR)-122 has recently been investigated as a potential biomarker of various hepatic diseases, such as chronic hepatitis and hepatocellular carcinoma (HCC). We investigated the association between plasma miR-122 levels and the treatment outcomes following transarterial chemoembolization (TACE) in HCC patients.